Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 

Paul Chous, M.A., OD Articles

Ordered by most recent

Article Title
Brief Description
I was recently asked by an interviewer to discuss common myths patients have about their eyes and vision, and it got me thinking. Over the years, I have compiled a mental list of patient (and physician) misunderstandings about diabetes and its effects on the eyes, and thought I might share at least some of them with you.

The Many Faces of Diabetic Eye Disease Paul Chous, M.A., O.D. Doctor of Optometry Type 1 diabetic since 1968
Paul Chous, M.A., O.D. and Type 1 diabetic since 1968 brings us an update on the Management of Diabetic Retinopathy in the 21st Century
Paul Chous, MA, OD, FAAO has had type one diabetes for over 30 years. He knows first hand the value of testing his glucose. Today he focuses on the New Blood Glucose Meters With the Eye Care Professional In Mind
This week Paul Chous, M.A., O.D., reflects on some data from the DPP, showing how pre-diabetes patients can develop Retinopathy. Paul, who has had type one diabetes for 38 years specializes in Diabetes Eye Care and has crafted a great explanation in Diabetic Retinopathy Without Diabetes?
Paul Chous, M.A., O.D. Doctor of Optometry Type 1 diabetic since 1968
Paul Chous, M.A., O.D. Doctor of Optometry Type 1 diabetic since 1968
Paul Chous, M.A., O.D. Doctor of Optometry Type 1 diabetic since 1968
Can evaluating retinal photoreceptor (rod and cone) distribution and function be used as an indicator of oncoming diabetic retinopathy? Paul Chous, M.A., O.D. Doctor of Optometry evaluates the possibility in his feature Are There Clinically Detectable Antecedents To Diabetic Retinopathy?
Paul Chous, M.A., O.D. Doctor of Optometry Type 1 diabetic since 1968 Diabetic retinopathy is the leading cause of new blindness for persons under age 74 in the US. Recognized risk factors for the development and progression of diabetic retinopathy include disease duration, poor glycemic control, hypertension and disease sub-type. , , Tight glycemic and hypertensive control comprise the mainstay of efforts to prevent and/or delay retinopathy , whereas laser photocoagulation is the current gold standard for ameliorating the risk of severe vision loss due to proliferative diabetic retinopathy (PDR) and clinically significant diabetic macular edema (CSDME).

Navigate through our listing of Paul Chous, M.A., OD articles here.

10 Total articles for Paul Chous, M.A., OD


Browse our other news categories below.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead | Case Study | Clinical Gems | Clinician Apps | Did You Know | Disasters Averted | Education | Exclusive Interviews | Facts | Feature | Homerun Slides: Clinical presentation library | How It Works | Items for the Week | Newsflash | Patient Apps | Press Releases | Product of the Week | Studies | Test Your Knowledge | Test Your Knowledge Answers | Tools | Videos |

Looking for a particular Newsletter Issue? Click Here

 
Diabetes In Control Advertisers
 
Cast Your Vote
Should a person newly diagnosed with prediabetes be treated with medication along with lifestyle changes?

Navigate Diabetes In Control
CME/CE of the Week
Jeffrey M. Robbins, DPM

Category: General Diabetes
Credits: .75


Advertisement


Search Articles On Diabetes In Control